Mile High Labs is an ISO 9001 and GMP-certified industrial-scale CBD manufacturer. The company offers reliable delivery of bulk CBD and white label services to the world’s leading consumer brands.

In October, Mile High Labs opened the doors of its new 400,000-square-foot facility in Broomfield, Colorado. The fully operational plant allows Mile High Labs to expand into the production of capsules, tablets, topicals, and gummies in addition to CBD isolate and distillate ingredients. The former pharmaceutical facility includes equipment and infrastructure for research and development, quality assurance, bottling, filling, packing, warehousing, labelling, shipping and compliance monitoring.

“This building will be the hub of innovation in the industry,” said Stephen Mueller, founder and CEO of Mile High Labs. “There is so much excitement surrounding hemp and cannabinoids. We hope this facility will spur other companies to collaborate and innovate in Colorado and create a cluster of cannabinoid innovation.”

The new facility will allow the company to scale and improve their industry-leading global distribution of CBD ingredients and finished products. Along with labs in Loveland and Broomfield, Colorado, Mile High Labs has offices and distribution centres in London and Belfast.

The European operation has enjoyed a period of rapid growth since it opened its European Headquarters in Belfast, Northern Ireland in March 2019. The company is seen across the CBD sector as a “best in class” proponent for better regulation, high standards of manufacturing and consumer protection. It is benefiting from a rapidly expanding market coupled with a growing reputation for quality and high manufacturing standards.

According to the Brightfield Group, the CBD market is projected to reach $22 billion by 2022. Market research commissioned by the Centre for Medicinal Cannabis in London estimates that the CBD market is currently one of the fastest growing wellbeing product categories in the UK. At the current rate it will be worth almost £1B per annum by 2025, equivalent in size to the current entire UK herbal supplement market.

A commitment to compliance, scalability and supply chain logistics makes Mile High Labs the premier CBD supplier of choice for worldwide brands.


E: [email protected]